{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:24:23Z","timestamp":1791869063735,"version":"4.3.4"},"reference-count":111,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijrobp.2025.09.050","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:26:09Z","timestamp":1758943569000},"page":"70-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of External Beam Radiation Therapy in Thyroid Cancer Management: A Scoping Review"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5512-4161","authenticated-orcid":false,"given":"Arnaud","family":"Beddok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Morvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurys","family":"Boudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Da Silva Ribeiro Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Dutheil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rozenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Theresette Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Zalzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Marcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.09.050_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0002","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","article-title":"Epidemiology of thyroid cancer","volume":"31","author":"Kitahara","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0003","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/thy.2013.0257","article-title":"The epidemic of thyroid cancer in the United States: The role of endocrinologists and ultrasounds","volume":"24","author":"Udelsman","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0004","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jnci\/djz202","article-title":"Impact of overweight and obesity on US papillary thyroid cancer incidence trends (1995-2015)","volume":"112","author":"Kitahara","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0005","unstructured":"SEER Cancer Statistics Review, 1975-2018. Howlader N, Noone AM, Krapcho M, et al (Eds). Bethesda, MD: National Cancer Institute; based on November 2020 SEER data submission, posted to the SEER web site, April 2021. Accessed November 23, 2025. https:\/\/seer.cancer.gov\/archive\/csr\/1975_2018\/"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0006","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.canrad.2022.01.003","article-title":"Impact of radiotherapy on survival in resected or unresectable anaplastic thyroid carcinomas, a Rare Cancer Network study","volume":"26","author":"Sun","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0007","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3390\/cancers13081913","article-title":"Prognostic value of the neutrophil-to-lymphocyte ratio before and after radiotherapy for anaplastic thyroid carcinoma","volume":"13","author":"Park","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0008","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00405-014-2937-2","article-title":"Influence of risk grouping on therapeutic decisions in patients with anaplastic thyroid carcinoma","volume":"272","author":"Sun","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0009","article-title":"An audit of medullary thyroid carcinoma from a tertiary care hospital in northwest India","volume":"14","author":"Chakraborty","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0011","author":"Wells","year":"2014","journal-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0012","article-title":"Combined radiation and chemotherapy versus monotherapy for anaplastic thyroid cancer: A SEER retrospective analysis","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12893-024-02375-6","article-title":"The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis","volume":"24","author":"Guo","year":"2024","journal-title":"BMC Surg"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13014-023-02249-w","article-title":"Prognostic factors in radiotherapy of anaplastic thyroid carcinoma: a single center study over 31 years","volume":"18","author":"Jacob","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0015","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1002\/cam4.5219","article-title":"Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma","volume":"12","author":"Yamazaki","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(22)00763-X","article-title":"Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG\/RTOG 0912): A randomised, double-blind, placebo-controlled, multicentre, phase 2 trial","volume":"24","author":"Sherman","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0017","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1007\/s00268-022-06739-y","article-title":"Impact of local control on clinical course in stage IVC anaplastic thyroid carcinoma","volume":"46","author":"Yamazaki","year":"2022","journal-title":"World J Surg"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.748023","article-title":"Radiotherapy plus chemotherapy leads to prolonged survival in patients with anaplastic thyroid cancer compared with radiotherapy alone regardless of surgical resection and distant metastasis: A retrospective population study","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0019","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1530\/EJE-20-1482","article-title":"Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: A real-world experience","volume":"184","author":"Park","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0020","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jamaoncol.2020.3362","article-title":"Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019","volume":"6","author":"Maniakas","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0021","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00405-020-05853-8","article-title":"Anaplastic thyroid carcinoma: Changing trends of treatment strategies and associated overall survival","volume":"277","author":"W\u00e4chter","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0022","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/hed.26086","article-title":"Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer","volume":"42","author":"Saeed","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0023","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hed.26042","article-title":"Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups","volume":"42","author":"Tian","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0024","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.21873\/anticanres.14722","article-title":"Survival and surgical complications in anaplastic thyroid cancer patients after completed multimodal treatment","volume":"40","author":"Lorntzsen","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0025","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.21037\/gs-20-503","article-title":"Multimodal treatment based on thyroidectomy improves survival in patients with metastatic anaplastic thyroid carcinoma: A SEER analysis from 1998 to 2015","volume":"9","author":"Song","year":"2020","journal-title":"Gland Surg"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0026","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.21037\/tcr-20-1364","article-title":"Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment","volume":"9","author":"Lee","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0027","doi-asserted-by":"crossref","first-page":"e9173","DOI":"10.7717\/peerj.9173","article-title":"Development and validation of a prognostic nomogram to predict overall survival and cancer-specific survival for patients with anaplastic thyroid carcinoma","volume":"8","author":"Gui","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0028","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/cncr.32548","article-title":"Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer","volume":"126","author":"Fan","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8218949","article-title":"Treatment outcomes in anaplastic thyroid cancer","volume":"2019","author":"Corrigan","year":"2019","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000493315","article-title":"Hypofractionated radiotherapy for anaplastic thyroid carcinoma: 15 years of experience in a single institution","volume":"8","author":"Takahashi","year":"2019","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8428547","article-title":"An update of the appropriate treatment strategies in anaplastic thyroid cancer: A population-based study of 735 patients","volume":"2019","author":"Huang","year":"2019","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0032","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3857\/roj.2018.00045","article-title":"Treatment outcomes of radiotherapy for anaplastic thyroid cancer","volume":"36","author":"Park","year":"2018","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0033","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2147\/OTT.S153759","article-title":"Evidence from an updated meta-analysis of the prognostic impacts of postoperative radiotherapy and chemotherapy in patients with anaplastic thyroid carcinoma","volume":"11","author":"Xia","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0034","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/cncr.30493","article-title":"Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base","volume":"123","author":"Pezzi","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1754-9485.12552","article-title":"Radiotherapy in anaplastic thyroid carcinoma: An Australian experience","volume":"61","author":"So","year":"2017","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0036","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1007\/s00405-017-4764-8","article-title":"Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery","volume":"274","author":"Jacobsen","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0037","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.adro.2016.05.001","article-title":"Orio PF 3rd. Neutron radiation therapy for advanced thyroid cancers","volume":"1","author":"Chapman","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0038","article-title":"Treatment and prognosis of anaplastic thyroid carcinoma: A clinical study of 50 cases","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0039","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejca.2016.02.015","article-title":"The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis","volume":"59","author":"Kwon","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0040","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.21873\/anticanres.11023","article-title":"Prognostic factors for survival in patients treated with multimodal therapy for anaplastic thyroid cancer","volume":"36","author":"K\u00e4smann","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0041","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1471-2407-14-235","article-title":"Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma","volume":"14","author":"He","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/764281","article-title":"Short course high dose radiotherapy in the treatment of anaplastic thyroid carcinoma","volume":"2014","author":"Stavas","year":"2014","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0043","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1748-717X-9-90","article-title":"Long-term results of radiotherapy in anaplastic thyroid cancer","volume":"9","author":"Dumke","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0044","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/jso.23177","article-title":"Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution","volume":"106","author":"Segerhammar","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0045","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2023-0146","article-title":"Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy","volume":"68","author":"Sol\u00f3rzano","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0046","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1245\/s10434-024-15356-z","article-title":"Single institution experience in the management of locally advanced (pT4) differentiated thyroid carcinomas","volume":"31","author":"Sessa","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0047","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/cen.14865","article-title":"Effect of postoperative radiotherapy for patients with differentiated thyroid cancer","volume":"98","author":"Ryu","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0048","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1038\/s41598-023-34269-7","article-title":"Prognostic value of adjuvant external beam radiotherapy for papillary thyroid cancer based on competitive risk model and propensity score matching","volume":"13","author":"Zhou","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0049","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14338\/IJPT-22-00005.1","article-title":"Outcomes and toxicities of nonmedullary thyroid tumors treated with proton beam radiation therapy","volume":"9","author":"Youssef","year":"2022","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0050","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1245\/s10434-022-11898-2","article-title":"Well-differentiated thyroid cancer: Who should get postoperative radiation?","volume":"29","author":"Adilbay","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.944758","article-title":"Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis","volume":"13","author":"Qian","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0052","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-21-0033","article-title":"Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer","volume":"11","author":"Groen","year":"2022","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0053","doi-asserted-by":"crossref","first-page":"832","DOI":"10.15537\/smj.2021.42.8.20210127","article-title":"The role of adjuvant radiation therapy for locoregionally recurrent papillary thyroid carcinoma","volume":"42","author":"Hwang","year":"2021","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0054","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12902-021-00826-2","article-title":"Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extension","volume":"21","author":"Weber","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.14338\/IJPT-D-20-00053","article-title":"Initial experience with proton beam therapy for differentiated thyroid cancer","volume":"8","author":"Yu","year":"2021","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0056","article-title":"Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0057","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijrobp.2021.05.006","article-title":"External beam radiation therapy in pT4 well-differentiated thyroid cancer: A population-based study of 405 patients","volume":"111","author":"Sit","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0058","article-title":"Treatment of unresectable differentiated thyroid carcinoma with upfront external radiotherapy and salvage surgery: A STROBE-compliant retrospective cohort study","volume":"10","author":"Carrillo","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0059","first-page":"383","article-title":"The role of lymph node status in cancer-specific survival and decision-making of postoperative radiotherapy in poorly differentiated thyroid cancer: A population-based study","volume":"13","author":"Zhang","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0060","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1245\/s10434-020-09023-2","article-title":"Prognostic impact of histologic grade for papillary thyroid carcinoma","volume":"28","author":"Ho","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0061","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1002\/cncr.33804","article-title":"Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial","volume":"127","author":"Romesser","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0062","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/cancers11060849","article-title":"10-year locoregional control with postoperative external beam radiotherapy in patients with locally advanced high-risk non-anaplastic thyroid carcinoma De Novo or at relapse, a propensity score analysis","volume":"11","author":"Servagi Vernat","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0063","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00268-018-4813-5","article-title":"Usefulness of stereotactic radiotherapy using the cyberKnife for patients with inoperable locoregional recurrences of differentiated thyroid cancer","volume":"43","author":"Ishigaki","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0064","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hed.25639","article-title":"Adjuvant external beam radiotherapy for locally invasive papillary thyroid cancer","volume":"41","author":"Megwalu","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2478\/raon-2018-0038","article-title":"Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience","volume":"52","author":"Besic","year":"2018","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0066","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1089\/thy.2018.0214","article-title":"Intensity-modulated radiation therapy with or without concurrent chemotherapy in nonanaplastic thyroid cancer with unresectable or gross residual disease","volume":"28","author":"Beckham","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0067","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamaoto.2017.2077","article-title":"Adjuvant external beam radiotherapy in locally advanced differentiated thyroid cancer","volume":"143","author":"Tam","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0068","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3857\/roj.2017.00192","article-title":"The role of adjuvant external beam radiation therapy for papillary thyroid carcinoma invading the trachea","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0069","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.3747\/co.24.3551","article-title":"Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy","volume":"24","author":"Vulpe","year":"2017","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0070","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1089\/thy.2016.0650","article-title":"Comparison of survival outcomes following postsurgical radioactive Iodine versus external beam radiation in stage IV differentiated thyroid carcinoma","volume":"27","author":"Yang","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0071","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40463-017-0221-3","article-title":"Patterns of regional recurrence in papillary thyroid cancer patients with lateral neck metastases undergoing neck dissection","volume":"46","author":"Xu","year":"2017","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0072","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/jc.2014-3242","article-title":"Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: Preliminary results of a phase II trial and propensity score analysis","volume":"100","author":"Lee","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0073","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/07435800.2013.879169","article-title":"The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: A long-term follow-up study","volume":"39","author":"Daliri","year":"2014","journal-title":"Endocr Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0074","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3857\/roj.2013.31.3.162","article-title":"Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer","volume":"31","author":"Kwon","year":"2013","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1089\/thy.2012.0083","article-title":"Quality of life impact of external beam radiotherapy for advanced thyroid carcinoma","volume":"23","author":"Gal","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0076","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hed.27584","article-title":"Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer","volume":"46","author":"Maniakas","year":"2024","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0077","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.21037\/tcr-21-1179","article-title":"Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis","volume":"10","author":"Huang","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0078","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12902-021-00832-4","article-title":"Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer","volume":"21","author":"Kukulska","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0079","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0194599820947696","article-title":"External beam radiotherapy for medullary thyroid cancer following total or near-total thyroidectomy","volume":"164","author":"Jin","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-19-0387","article-title":"The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma","volume":"9","author":"Kukulska","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0081","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.4081\/rt.2013.e37","article-title":"A role for radiotherapy in the management of advanced medullary thyroid carcinoma: The mayo clinic experience","volume":"5","author":"Call","year":"2013","journal-title":"Rare Tumors"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0082","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.956289","article-title":"Clinical analysis of 13 cases of primary squamous-cell thyroid carcinoma","volume":"12","author":"Ou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0083","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1097\/AS9.0000000000000226","article-title":"Prognostic nomogram and competing risk analysis of death for primary thyroid lymphoma: A long-term survival study of 1638 patients","volume":"3","author":"Zhang","year":"2022","journal-title":"Ann Surg Open"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0084","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.795184","article-title":"Oncocytic papillary thyroid carcinoma and oncocytic poorly differentiated thyroid carcinoma: Clinical features, uptake, and response to radioactive Iodine therapy, and outcome","volume":"12","author":"Lukovic","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0085","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/MNM.0000000000001049","article-title":"Clinicopathological features and outcomes after radioactive iodine treatment of oncocytic well-differentiated thyroid carcinomas","volume":"40","author":"Amouri","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0086","doi-asserted-by":"crossref","first-page":"683","DOI":"10.21037\/gs.2019.11.07","article-title":"Treatment optimization and prognostic considerations for primary squamous cell carcinoma of the thyroid","volume":"8","author":"Wang","year":"2019","journal-title":"Gland Surg"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0087","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1007\/s00259-019-04456-8","article-title":"Long-term outcome of rare oncocytic papillary (H\u00fcrthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy","volume":"46","author":"Wenter","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0088","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00268-019-04906-2","article-title":"Primary squamous cell carcinoma in the thyroid gland: A population-based analysis using the SEER database","volume":"43","author":"Yang","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0089","first-page":"592","article-title":"Primary squamous-cell thyroid carcinoma\u2014a successful treatment with five-year follow-up","volume":"68","author":"Wygoda","year":"2017","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4174\/astr.2015.89.6.295","article-title":"Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study","volume":"89","author":"Chai","year":"2015","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0091","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1089\/thy.2013.0523","article-title":"Rituximab-including combined modality treatment for primary thyroid lymphoma: An effective regimen for elderly patients","volume":"24","author":"Watanabe","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0092","first-page":"4427","article-title":"Hypothyroidism after radiotherapy for primary thyroid lymphoma","volume":"34","author":"Ishibashi","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0093","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3857\/roj.2013.31.4.177","article-title":"Patterns of care and treatment outcomes for primary thyroid lymphoma: A single institution study","volume":"31","author":"Cha","year":"2013","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0094","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/thy.2021.0628","article-title":"Radiotherapy for brain metastases from thyroid cancer: An institutional and national retrospective cohort study","volume":"32","author":"Blomain","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0095","doi-asserted-by":"crossref","first-page":"E1188","DOI":"10.1097\/BRS.0000000000003087","article-title":"Clinical efficacy of frameless stereotactic radiosurgery in the management of spinal metastases from thyroid carcinoma","volume":"44","author":"Hariri","year":"2019","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0096","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jrr\/rrz056","article-title":"Stereotactic radiotherapy using the CyberKnife is effective for local control of bone metastases from differentiated thyroid cancer","volume":"60","author":"Ishigaki","year":"2019","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0097","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1097\/RLU.0000000000002626","article-title":"Thyroid cancer bone metastasis: Survival and genomic characteristics of a large tertiary care cohort","volume":"44","author":"Kondraciuk","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0098","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000494719","article-title":"Bone metastases from thyroid carcinoma of follicular origin: A single institutional experience","volume":"8","author":"Matta-Coelho","year":"2019","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0099","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/RLU.0000000000002618","article-title":"Thyroid cancer brain metastasis: Survival and genomic characteristics of a large tertiary care cohort","volume":"44","author":"Osborne","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0100","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1089\/thy.2019.0086","article-title":"A phase 2 study of pembrolizumab combined with chemoradiotherapy as initial treatment for anaplastic thyroid cancer","volume":"29","author":"Chintakuntlawar","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0101","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1200\/JCO.2025.43.16_suppl.6008","article-title":"Neoadjuvant pembrolizumab in combination with dabrafenib and trametinib (DTP) for BRAF V600E-mutated anaplastic thyroid cancer (BRAFm-ATC): A multicenter phase 2 trial","volume":"43","author":"Zafereo","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0102","first-page":"316","article-title":"Primary thyroid lymphoma","volume":"26","author":"Ansell","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0104","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/0300891621996817","article-title":"Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: Systematic review and meta-analysis","volume":"107","author":"Dicuonzo","year":"2021","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/thy.2017.0285","article-title":"Real-world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma","volume":"28","author":"Iyer","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0106","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.annonc.2021.12.014","article-title":"Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: Updated analysis from the phase II ROAR basket study","volume":"33","author":"Subbiah","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0107","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1089\/thy.2022.0504","article-title":"Surgery after BRAF-directed therapy is associated with improved survival in BRAFV600E mutant anaplastic thyroid cancer: A single-center retrospective cohort study","volume":"33","author":"Zhao","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0108","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/jamaoncol.2024.2133","article-title":"Initial management of BRAF V600E-variant anaplastic thyroid cancer: The FAST multidisciplinary group consensus statement","volume":"10","author":"Hamidi","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0109","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1089\/thy.2020.0322","article-title":"Combination of lenvatinib and pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma","volume":"31","author":"Dierks","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s40792-022-01496-5","article-title":"Primary thyroid gland myxofibrosarcoma: a case report and review of the literature","volume":"8","author":"Stylianidi","year":"2022","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.ijrobp.2025.09.050_bib0111","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.oraloncology.2018.05.004","article-title":"Primary thyroid angiosarcoma: A systematic review","volume":"82","author":"De Felice","year":"2018","journal-title":"Oral Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625063138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625063138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:48:06Z","timestamp":1791654486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625063138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0360301625063138"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.09.050","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of External Beam Radiation Therapy in Thyroid Cancer Management: A Scoping Review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.09.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}